Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

A comparison of the effects of oral contraceptives on the clinical and biochemical manifestations of polycystic ovary syndrome: a crossover randomized controlled trial.

Amiri M, Nahidi F, Bidhendi-Yarandi R, Khalili D, Tohidi M, Ramezani Tehrani F.

Hum Reprod. 2020 Jan 9. pii: dez255. doi: 10.1093/humrep/dez255. [Epub ahead of print]

PMID:
31916574
2.

Comparing different definitions of prediabetes with subsequent risk of diabetes: an individual participant data meta-analysis involving 76 513 individuals and 8208 cases of incident diabetes.

Lee CMY, Colagiuri S, Woodward M, Gregg EW, Adams R, Azizi F, Gabriel R, Gill TK, Gonzalez C, Hodge A, Jacobs Jr DR Jr, Joseph JJ, Khalili D, Magliano DJ, Mehlig K, Milne R, Mishra G, Mongraw-Chaffin M, Pasco JA, Sakurai M, Schreiner PJ, Selvin E, Shaw JE, Wittert G, Yatsuya H, Huxley RR.

BMJ Open Diabetes Res Care. 2019 Dec 29;7(1):e000794. doi: 10.1136/bmjdrc-2019-000794. eCollection 2019.

3.

Relationship between lifestyle pattern and blood pressure - Iranian national survey.

Akbarpour S, Khalili D, Zeraati H, Mansournia MA, Ramezankhani A, Ahmadi Pishkuhi M, Rostami Gooran S, Fotouhi A.

Sci Rep. 2019 Oct 23;9(1):15194. doi: 10.1038/s41598-019-51309-3.

4.

Metabolic health in the Middle East and north Africa.

Azizi F, Hadaegh F, Hosseinpanah F, Mirmiran P, Amouzegar A, Abdi H, Asghari G, Parizadeh D, Montazeri SA, Lotfaliany M, Takyar F, Khalili D.

Lancet Diabetes Endocrinol. 2019 Nov;7(11):866-879. doi: 10.1016/S2213-8587(19)30179-2. Epub 2019 Aug 14. Review.

PMID:
31422063
5.

Audit of the Congenital Hypothyroidism Screening Program in 15 Provinces of Iran.

Mehran L, Yarahmadi S, Khalili D, Hedayati M, Amouzegar A, Mousapour P, Ajang N, Azizi F.

Arch Iran Med. 2019 Jun 1;22(6):310-317.

6.

Yorkie controls tube length and apical barrier integrity during airway development.

Skouloudaki K, Christodoulou I, Khalili D, Tsarouhas V, Samakovlis C, Tomancak P, Knust E, Papadopoulos DK.

J Cell Biol. 2019 Aug 5;218(8):2762-2781. doi: 10.1083/jcb.201809121. Epub 2019 Jul 17.

PMID:
31315941
7.

Increased Remission Rates After Long-Term Methimazole Therapy in Patients with Graves' Disease: Results of a Randomized Clinical Trial.

Azizi F, Amouzegar A, Tohidi M, Hedayati M, Khalili D, Cheraghi L, Mehrabi Y, Takyar M.

Thyroid. 2019 Sep;29(9):1192-1200. doi: 10.1089/thy.2019.0180. Epub 2019 Aug 28.

PMID:
31310160
8.

Can Supplementation with Vitamin D Modify Thyroid Autoantibodies (Anti-TPO Ab, Anti-Tg Ab) and Thyroid Profile (T3, T4, TSH) in Hashimoto's Thyroiditis? A Double Blind, Randomized Clinical Trial.

Chahardoli R, Saboor-Yaraghi AA, Amouzegar A, Khalili D, Vakili AZ, Azizi F.

Horm Metab Res. 2019 May;51(5):296-301. doi: 10.1055/a-0856-1044. Epub 2019 May 9.

PMID:
31071734
9.

Iran in transition.

Danaei G, Farzadfar F, Kelishadi R, Rashidian A, Rouhani OM, Ahmadnia S, Ahmadvand A, Arabi M, Ardalan A, Arhami M, Azizi MH, Bahadori M, Baumgartner J, Beheshtian A, Djalalinia S, Doshmangir L, Haghdoost AA, Haghshenas R, Hosseinpoor AR, Islami F, Kamangar F, Khalili D, Madani K, Masoumi-Asl H, Mazyaki A, Mirchi A, Moradi E, Nayernouri T, Niemeier D, Omidvari AH, Peykari N, Pishgar F, Qorbani M, Rahimi K, Rahimi-Movaghar A, Tehrani FR, Rezaei N, Shahraz S, Takian A, Tootee A, Ezzati M, Jamshidi HR, Larijani B, Majdzadeh R, Malekzadeh R.

Lancet. 2019 May 11;393(10184):1984-2005. doi: 10.1016/S0140-6736(18)33197-0. Epub 2019 Apr 28. Review. Erratum in: Lancet. 2019 May 25;393(10186):2124.

PMID:
31043324
10.

Non-invasive Risk Prediction Models in Identifying Undiagnosed Type 2 Diabetes or Predicting Future Incident Cases in the Iranian Population.

Lotfaliany M, Hadaegh F, Asgari S, Mansournia MA, Azizi F, Oldenburg B, Khalili D.

Arch Iran Med. 2019 Mar 1;22(3):116-124.

11.

Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012-2015.

Asgari S, Khaloo P, Khalili D, Azizi F, Hadaegh F.

Sci Rep. 2019 Apr 23;9(1):6382. doi: 10.1038/s41598-019-42809-3.

12.

Correction to: National trends of pre-hypertension and hypertension among Iranian adolescents across urban and rural areas (2007-2011).

Amiri P, Vahedi-Notash G, Naseri P, Khalili D, Hashemi Nazari SS, Mehrabi Y, Mahdavi Hazaveh AR, Azizi F, Hadaegh F.

Biol Sex Differ. 2019 Apr 15;10(1):18. doi: 10.1186/s13293-019-0234-x.

13.

National trends of pre-hypertension and hypertension among Iranian adolescents across urban and rural areas (2007-2011).

Amiri P, Vahedi-Notash G, Naseri P, Khalili D, Hashemi Nazari SS, Mehrabi Y, Mahdavi Hazaveh AR, Azizi F, Hadaegh F.

Biol Sex Differ. 2019 Mar 29;10(1):15. doi: 10.1186/s13293-019-0230-1. Erratum in: Biol Sex Differ. 2019 Apr 15;10(1):18.

14.

Long-Term Effectiveness of a Lifestyle Intervention: A Pragmatic Community Trial to Prevent Metabolic Syndrome.

Khalili D, Asgari S, Lotfaliany M, Zafari N, Hadaegh F, Momenan AA, Nowroozpoor A, Hosseini-Esfahani F, Mirmiran P, Amiri P, Azizi F.

Am J Prev Med. 2019 Mar;56(3):437-446. doi: 10.1016/j.amepre.2018.10.029.

PMID:
30777162
15.

Association between duration of endogenous estrogen exposure and cardiovascular outcomes: A population - based cohort study.

Farahmand M, Ramezani Tehrani F, Khalili D, Cheraghi L, Bahri Khomami M, Azizi F.

Life Sci. 2019 Mar 15;221:335-340. doi: 10.1016/j.lfs.2019.02.020. Epub 2019 Feb 11.

PMID:
30763578
16.

Application of Latent Class Analysis to Identify Metabolic Syndrome Components Patterns in adults: Tehran Lipid and Glucose study.

Ahanchi NS, Hadaegh F, Alipour A, Ghanbarian A, Azizi F, Khalili D.

Sci Rep. 2019 Feb 7;9(1):1572. doi: 10.1038/s41598-018-38095-0.

17.

Impact of temperature and air pollution on cardiovascular disease and death in Iran: A 15-year follow-up of Tehran Lipid and Glucose Study.

Khajavi A, Khalili D, Azizi F, Hadaegh F.

Sci Total Environ. 2019 Apr 15;661:243-250. doi: 10.1016/j.scitotenv.2019.01.182. Epub 2019 Jan 15.

PMID:
30677672
18.

Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Ramezankhani A, Harati H, Bozorgmanesh M, Tohidi M, Khalili D, Azizi F, Hadaegh F.

Int J Endocrinol Metab. 2018 Oct 16;16(4 Suppl):e84784. doi: 10.5812/ijem.84784. eCollection 2018 Oct. Review.

19.

Outcomes of a Longitudinal Population-based Cohort Study and Pragmatic Community Trial: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Khalili D, Azizi F, Asgari S, Zadeh-Vakili A, Momenan AA, Ghanbarian A, Eskandari F, Sheikholeslami F, Hadaegh F.

Int J Endocrinol Metab. 2018 Oct 13;16(4 Suppl):e84748. doi: 10.5812/ijem.84748. eCollection 2018 Oct. Review.

20.

Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study.

Behboudi-Gandevani S, Ramezani Tehrani F, Hosseinpanah F, Khalili D, Cheraghi L, Kazemijaliseh H, Azizi F.

Fertil Steril. 2018 Dec;110(7):1377-1386. doi: 10.1016/j.fertnstert.2018.08.046.

PMID:
30503137
21.

World Bank Income Group, Health Expenditure or Cardiometabolic Risk Factors? A Further Explanation of the Wide Gap in Cardiometabolic Mortality Between Worldwide Countries: An Ecological Study.

Lotfaliany M, Akbarpour S, Zafari N, Mansournia MA, Asgari S, Azizi F, Hadaegh F, Khalili D.

Int J Endocrinol Metab. 2018 Jul 10;16(3):e59946. doi: 10.5812/ijem.59946. eCollection 2018 Jul.

22.

Lifestyle patterns in the Iranian population: Self- organizing map application.

Akbarpour S, Khalili D, Zeraati H, Mansournia MA, Ramezankhanim A, Fotouhi A.

Caspian J Intern Med. 2018 Summer;9(3):268-275. doi: 10.22088/cjim.9.3.268.

23.

Cardiovascular mortality in a Western Asian country: results from the Iran Cohort Consortium.

Fahimfar N, Khalili D, Sepanlou SG, Malekzadeh R, Azizi F, Mansournia MA, Roohafza H, Emamian MH, Hadaegh F, Poustchi H, Mansourian M, Hashemi H, Sharafkhah M, Pourshams A, Farzadfar F, Steyerberg EW, Fotouhi A.

BMJ Open. 2018 Jul 5;8(7):e020303. doi: 10.1136/bmjopen-2017-020303.

24.

Optimal cut-points of different anthropometric indices and their joint effect in prediction of type 2 diabetes: results of a cohort study.

Zafari N, Lotfaliany M, Mansournia MA, Khalili D, Azizi F, Hadaegh F.

BMC Public Health. 2018 Jun 5;18(1):691. doi: 10.1186/s12889-018-5611-6.

25.

Direct and indirect effects of central and general adiposity on cardiovascular diseases: The Tehran Lipid and Glucose Study.

Bakhtiyari M, Schmidt N, Hadaegh F, Khalili D, Mansournia N, Asgari S, Mansournia MA.

Eur J Prev Cardiol. 2018 Jul;25(11):1170-1181. doi: 10.1177/2047487318780030. Epub 2018 Jun 1.

PMID:
29856228
26.

Healthy lifestyle behaviors and control of hypertension among adult hypertensive patients.

Akbarpour S, Khalili D, Zeraati H, Mansournia MA, Ramezankhani A, Fotouhi A.

Sci Rep. 2018 May 31;8(1):8508. doi: 10.1038/s41598-018-26823-5.

27.

12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study.

Rabani S, Sardarinia M, Akbarpour S, Azizi F, Khalili D, Hadaegh F.

PLoS One. 2018 May 16;13(5):e0195543. doi: 10.1371/journal.pone.0195543. eCollection 2018.

28.

The Effects of a Community-Based Lifestyle Intervention on Metabolic Syndrome and Its Components in Adolescents: Findings of a Decade Follow-Up.

Amiri P, Jalali-Farahani S, Akbar HM, Cheraghi L, Khalili D, Momenan A, Mirmiran P, Ghanbarian A, Hedayati M, Hosseini-Esfahani F, Azizi F.

Metab Syndr Relat Disord. 2018 Jun;16(5):215-223. doi: 10.1089/met.2017.0055. Epub 2018 Apr 12.

PMID:
29648906
29.

The Burden of Statin Therapy based on ACC/AHA and NCEP ATP-III Guidelines: An Iranian Survey of Non-Communicable Diseases Risk Factors.

Asgari S, Abdi H, Hezaveh AM, Moghisi A, Etemad K, Beni HR, Khalili D.

Sci Rep. 2018 Mar 21;8(1):4928. doi: 10.1038/s41598-018-23364-9.

30.

Evaluation of the congenital hypothyroidism screening programme in Iran: a 3-year retrospective cohort study.

Mehran L, Khalili D, Yarahmadi S, Delshad H, Mehrabi Y, Amouzegar A, Ajang N, Azizi F.

Arch Dis Child Fetal Neonatal Ed. 2019 Mar;104(2):F176-F181. doi: 10.1136/archdischild-2017-313720. Epub 2018 Mar 14.

PMID:
29540462
31.

Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study.

Kabootari M, Asgari S, Mansournia MA, Khalili D, Valizadeh M, Azizi F, Hadaegh F.

J Am Heart Assoc. 2018 Feb 10;7(4). pii: e006924. doi: 10.1161/JAHA.117.006924.

32.

Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study.

Kazemi Jaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Cheraghi L, Azizi F.

Fertil Steril. 2017 Dec;108(6):1078-1084. doi: 10.1016/j.fertnstert.2017.09.004.

PMID:
29202960
33.

Worldwide Recall Rate in Newborn Screening Programs for Congenital Hypothyroidism.

Mehran L, Khalili D, Yarahmadi S, Amouzegar A, Mojarrad M, Ajang N, Azizi F.

Int J Endocrinol Metab. 2017 Jun 25;15(3):e55451. doi: 10.5812/ijem.55451. eCollection 2017 Jul. Review.

34.

Predictors of early adulthood hypertension during adolescence: a population-based cohort study.

Kalantari S, Khalili D, Asgari S, Fahimfar N, Hadaegh F, Tohidi M, Azizi F.

BMC Public Health. 2017 Nov 28;17(1):915. doi: 10.1186/s12889-017-4922-3.

35.

Anthropometric Indices as Predictors of Coronary Heart Disease Risk: Joint Modeling of Longitudinal Measurements and Time to Event.

Gilani N, Kazemnejad A, Zayeri F, Hadaegh F, Azizi F, Khalili D.

Iran J Public Health. 2017 Nov;46(11):1546-1554.

36.

The Impact of Iodine Status on the Recall Rate of the Screening Program for Congenital Hypothyroidism: Findings from Two National Studies in Iran.

Mehran L, Yarahmadi S, Khalili D, Nazeri P, Delshad H, Abdollahi Z, Azhang N, Azizi F.

Nutrients. 2017 Oct 30;9(11). pii: E1194. doi: 10.3390/nu9111194.

37.

Determining the Factors Associated with Cardiovascular Disease Recurrence: Tehran Lipid and Glucose Study.

Taravatmanesh S, Khalili D, Khodakarim S, Asgari S, Hadaegh F, Azizi F, Sabour S.

J Tehran Heart Cent. 2017 Jul;12(3):107-113. Review.

38.

A Population-Based Study of the Prevalence of Abnormal Uterine Bleeding and its Related Factors among Iranian Reproductive-Age Women: An Updated Data.

Kazemijaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Khalili D, Hosseinpanah F, Azizi F.

Arch Iran Med. 2017 Sep;20(9):558-563. doi: 0172009/AIM.003.

40.

Risk of Coronary Heart Events Based on Rose Angina Questionnaire and ECG Besides Diabetes and Other Metabolic Risk Factors: Results of a 10-Year Follow-up in Tehran Lipid and Glucose Study.

Mansournia MA, Holakouie-Naieni K, Fahimfar N, Almasi-Hashiani A, Cheraghi Z, Ayubi E, Hadaegh F, Eskandari F, Azizi F, Khalili D.

Int J Endocrinol Metab. 2017 Apr 24;15(2):e42713. doi: 10.5812/ijem.42713. eCollection 2017 Apr.

41.

Factors associated with the severity of premenstrual syndrome among Iranian college students.

Farahmand M, Ramezani Tehrani F, Khalili D, Amin G, Negarandeh R.

J Obstet Gynaecol Res. 2017 Nov;43(11):1726-1731. doi: 10.1111/jog.13439. Epub 2017 Jul 24.

PMID:
28737241
42.

A new look at risk patterns related to coronary heart disease incidence using survival tree analysis: 12 Years Longitudinal Study.

Ramezankhani A, Bagherzadeh-Khiabani F, Khalili D, Azizi F, Hadaegh F.

Sci Rep. 2017 Jun 12;7(1):3237. doi: 10.1038/s41598-017-03577-0.

43.

Rationale and Design of a Genetic Study on Cardiometabolic Risk Factors: Protocol for the Tehran Cardiometabolic Genetic Study (TCGS).

Daneshpour MS, Fallah MS, Sedaghati-Khayat B, Guity K, Khalili D, Hedayati M, Ebrahimi A, Hajsheikholeslami F, Mirmiran P, Ramezani Tehrani F, Momenan AA, Ghanbarian A, Amouzegar A, Amiri P, Azizi F.

JMIR Res Protoc. 2017 Feb 23;6(2):e28. doi: 10.2196/resprot.6050.

44.

White rice intake and incidence of type-2 diabetes: analysis of two prospective cohort studies from Iran.

Golozar A, Khalili D, Etemadi A, Poustchi H, Fazeltabar A, Hosseini F, Kamangar F, Khoshnia M, Islami F, Hadaegh F, Brennan P, Boffetta P, Abnet CC, Dawsey SM, Azizi F, Malekzadeh R, Danaei G.

BMC Public Health. 2017 Jan 31;17(1):133. doi: 10.1186/s12889-016-3999-4.

45.

Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.

Ueda P, Woodward M, Lu Y, Hajifathalian K, Al-Wotayan R, Aguilar-Salinas CA, Ahmadvand A, Azizi F, Bentham J, Cifkova R, Di Cesare M, Eriksen L, Farzadfar F, Ferguson TS, Ikeda N, Khalili D, Khang YH, Lanska V, León-Muñoz L, Magliano DJ, Margozzini P, Msyamboza KP, Mutungi G, Oh K, Oum S, Rodríguez-Artalejo F, Rojas-Martinez R, Valdivia G, Wilks R, Shaw JE, Stevens GA, Tolstrup JS, Zhou B, Salomon JA, Ezzati M, Danaei G.

Lancet Diabetes Endocrinol. 2017 Mar;5(3):196-213. doi: 10.1016/S2213-8587(17)30015-3. Epub 2017 Jan 24.

46.

Comparison of the Effect of Gastric Bypass and Sleeve Gastrectomy on Metabolic Syndrome and its Components in a Cohort: Tehran Obesity Treatment Study (TOTS).

Barzin M, Motamedi MAK, Serahati S, Khalaj A, Arian P, Valizadeh M, Khalili D, Azizi F, Hosseinpanah F.

Obes Surg. 2017 Jul;27(7):1697-1704. doi: 10.1007/s11695-016-2526-0.

PMID:
28054293
47.

Sex-specific incidence rates and risk factors of premature cardiovascular disease. A long term follow up of the Tehran Lipid and Glucose Study.

Eslami A, Mozaffary A, Derakhshan A, Azizi F, Khalili D, Hadaegh F.

Int J Cardiol. 2017 Jan 15;227:826-832. doi: 10.1016/j.ijcard.2016.10.037. Epub 2016 Oct 17.

PMID:
27829526
48.

Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study.

Asgari S, Barzin M, Hosseinpanah F, Hadaegh F, Azizi F, Khalili D.

Int J Endocrinol Metab. 2016 Apr 16;14(2):e37018. eCollection 2016 Apr.

49.

A Challenging Interaction of Chronic Kidney Disease With Other Metabolic Disorders: Paradoxes in Cardiometabolic Risk Factors.

Panahi MH, Hadaegh F, Yavari P, Kazempour-Ardebili S, Mehrabi Y, Azizi F, Khalili D.

Iran J Kidney Dis. 2016 Sep;10(5):274-281.

50.

The association between nutritional exposures and metabolic syndrome in the Tehran Lipid and Glucose Study (TLGS): a cohort study.

Cheraghi Z, Mirmiran P, Mansournia MA, Moslehi N, Khalili D, Nedjat S.

Public Health. 2016 Nov;140:163-171. doi: 10.1016/j.puhe.2016.07.003. Epub 2016 Aug 5.

PMID:
27498945

Supplemental Content

Loading ...
Support Center